Sourced guides

Read the day. Understand the night.

Understand hot-flash outcomes, night sweats, sleep and medicine-specific safety. Each guide includes sources and questions to take into a clinical conversation.

Guide

Fewer flashes, milder flashes, easier days: three different treatment goals

A hot-flash count, an intensity rating and an account of interrupted life answer different questions. Keep all three visible when discussing relief.

Guide

Night sweats and sleep: describe the waking, not just the heat

Separate heat-related awakenings, trouble returning to sleep and daytime tiredness before assuming one menopause treatment will resolve them all.

Guide

Nonhormonal treatment still needs a medicine-specific safety review

Paroxetine, fezolinetant and elinzanetant have different interactions, precautions and follow-up duties. Do not combine them into one safety profile.

Guide

Read a hot-flash treatment claim in six questions

Who was studied, compared with what, measuring which outcome, for how long, using which exact product—and what does the claim leave unresolved?

Guide

Paroxetine Hot-Flash Trials: Nighttime Awakenings and Sleep Duration

Two placebo-controlled trials support low-dose paroxetine for menopausal hot flashes. Their sleep analysis found modest additional gains in nighttime waking and sleep duration, with important differences across outcomes.

Guide

SKYLIGHT 1: Fezolinetant Symptom Results and Current Liver-Safety Evidence

The 527-participant randomized trial established a benefit for hot-flash frequency and severity over 12 weeks. Its extension, separate sleep research, and current boxed liver warning answer different questions.